AT
Addex Therapeutics Ltd
🇺🇸XNAS.ADXNUnited StatesHealthcare
$3.49USDup +0.10 (+2.95%)OpenEnd of day2:22 PM
Price$3.49+0.10 (+2.95%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US00654J2069
- CUSIP
- 00654J107
Company
- Employees
- 3
- Headquarters
- Geneva, United States
- CEO
- Mr. Timothy Mark Dyer
Market
- Shares outstanding
- 1.3M
- Market cap
- $4.42M
Key dates
- Next earnings
- Oct 5, 2026
Highlights
- Market cap
- $4.42M
- EPS LTM
- -CHFÂ 5.21
- P/E LTM
- -1.21
- Div yield
- 0%
Fundamentals (LTM)
- Revenue
- CHFÂ 93.6K-45.62%down year on year
- Net income
- -CHFÂ 7.43M-185.68%down year on year
- Gross margin
- -191.93%-2.52%down year on year
- Free cash flow
- -CHFÂ 2.33M+38.42%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.